| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Jun 2026 | 1 Jun 2026 |
| Boston Commerce Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2026 inter alia to consider and approve Prior intimation for the board meeting to be held on 5th June 2026 for considering reduction of share capital of the company | ||
| Board Meeting | 30 May 2026 | 25 May 2026 |
| Boston Commerce Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 30th May 2026 | ||
| Board Meeting | 12 May 2026 | 12 May 2026 |
| Outcome of the Board meeting held on 12th May, 2026 | ||
| Board Meeting | 13 Feb 2026 | 10 Feb 2026 |
| Quarterly Results. Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Prior Intimation for the Board Meeting to be held on 13th February, 2026 Outcome of Board Meeting held on 13th February, 2026 pursuant to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements)Regulation, 2015 Unaudited financial results for the quarter ended 31st December, 2025 (As Per BSE Announcement Dated on:13.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025 under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 held today i.e. 14th November, 2025. Unaudited Financial Results of the company for the quarter and half year ended on 30th September, 2025. (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 4 Sep 2025 | 4 Sep 2025 |
| Please find enclosed the outcome of the Board Meeting | ||
| Board Meeting | 14 Aug 2025 | 8 Aug 2025 |
| Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Intimation for board meeting to be held on 14th August 2025 for considering the unaudited financial results for the quarter ended 30th June 2025. Please Find Enclosed Herewith Outcome of the Board Meeting For Your Records for the Quarter Ended 30th June 2025 (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 8 Jul 2025 | 8 Jul 2025 |
| Please find enclosed the Outcome of Board Meeting held on 08th July, 2025 of Boston Bio Systems Limited | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
